The company 23andMe is based out of San Francisco and is now left with a single board member, Wojcicki who controls 49.75 per ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...

Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

"Most 'wellness companies' test for specific genes. They will produce a report outlining dietary advice based on your genetic ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

DNA testing company 23andMe is in financial crisis, raising questions about what will happen to the data it holds on 15 milli ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...